Advesya
Besançon, FR · 1 known investors
Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).
Founders & leadership
CF
Christophe FerrandinFounder and Board Member (Director of R&D)
MD
Marina DeschampsinFounder (Director of CMC)
AB
Board
KP
Ksenija PavleticinA.I. Chief Executive OfficerGeneral Partner & Chief Commercial Officer at Jeito Capital
Investors · 1
Frequently asked questions
- What does Advesya do?
- Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).
- Who founded Advesya?
- Advesya was founded by Christophe Ferrand, Marina Deschamps, André Baruchel.
- Who are Advesya's investors?
- Advesya's investors include Jeito Capital.
- Where is Advesya headquartered?
- Advesya is headquartered in Besançon, FR.